147 related articles for article (PubMed ID: 24859391)
1. Nanosuspension for the delivery of a poorly soluble anti-cancer kinase inhibitor.
Danhier F; Ucakar B; Vanderhaegen ML; Brewster ME; Arien T; Préat V
Eur J Pharm Biopharm; 2014 Sep; 88(1):252-60. PubMed ID: 24859391
[TBL] [Abstract][Full Text] [Related]
2. Active and passive tumor targeting of a novel poorly soluble cyclin dependent kinase inhibitor, JNJ-7706621.
Danhier F; Ucakar B; Magotteaux N; Brewster ME; Préat V
Int J Pharm; 2010 Jun; 392(1-2):20-8. PubMed ID: 20226846
[TBL] [Abstract][Full Text] [Related]
3. Development of PIK-75 nanosuspension formulation with enhanced delivery efficiency and cytotoxicity for targeted anti-cancer therapy.
Talekar M; Ganta S; Amiji M; Jamieson S; Kendall J; Denny WA; Garg S
Int J Pharm; 2013 Jun; 450(1-2):278-89. PubMed ID: 23632263
[TBL] [Abstract][Full Text] [Related]
4. Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for paclitaxel.
Danhier F; Magotteaux N; Ucakar B; Lecouturier N; Brewster M; Préat V
Eur J Pharm Biopharm; 2009 Oct; 73(2):230-8. PubMed ID: 19577643
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of pluronic nanosuspensions loading a novel insoluble anticancer drug both in vitro and in vivo.
Tang XJ; Fu YH; Meng QH; Li LM; Ying XY; Han M; He QJ; Yang B; Zeng S; Hu YZ; Sheng XX; Gao JQ
Int J Pharm; 2013 Nov; 456(1):243-50. PubMed ID: 23928148
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel nanosuspensions for targeted chemotherapy - nanosuspension preparation, characterization, and use.
Lee SE; Bairstow SF; Werling JO; Chaubal MV; Lin L; Murphy MA; DiOrio JP; Gass J; Rabinow B; Wang X; Zhang Y; Yang Z; Hoffman RM
Pharm Dev Technol; 2014 Jun; 19(4):438-53. PubMed ID: 23617261
[TBL] [Abstract][Full Text] [Related]
7. [Advances in the study of tumor pH-responsive polymeric micelles for cancer drug targeting delivery].
Xu JX; Tang JB; Zhao LH; Shen YQ
Yao Xue Xue Bao; 2009 Dec; 44(12):1328-35. PubMed ID: 21351464
[TBL] [Abstract][Full Text] [Related]
8. Nanosuspension for parenteral delivery of a p-terphenyl derivative: preparation, characteristics and pharmacokinetic studies.
Tian X; Li H; Zhang D; Liu G; Jia L; Zheng D; Shen J; Shen Y; Zhang Q
Colloids Surf B Biointerfaces; 2013 Aug; 108():29-33. PubMed ID: 23528604
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a crystalline nanosuspension: polymorphism, process induced transformation and in vivo studies.
Sharma P; Zujovic ZD; Bowmaker GA; Marshall AJ; Denny WA; Garg S
Int J Pharm; 2011 Apr; 408(1-2):138-51. PubMed ID: 21272627
[TBL] [Abstract][Full Text] [Related]
10. Formulation and pharmacokinetic evaluation of an asulacrine nanocrystalline suspension for intravenous delivery.
Ganta S; Paxton JW; Baguley BC; Garg S
Int J Pharm; 2009 Feb; 367(1-2):179-86. PubMed ID: 18848873
[TBL] [Abstract][Full Text] [Related]
11. Particle size reduction for improvement of oral absorption of the poorly soluble drug UG558 in rats during early development.
Sigfridsson K; Lundqvist AJ; Strimfors M
Drug Dev Ind Pharm; 2009 Dec; 35(12):1479-86. PubMed ID: 19929207
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel nanosuspension coated with P-gp inhibitory surfactants: II. Ability to reverse the drug-resistance of H460 human lung cancer cells.
Gao L; Liu G; Ma J; Wang X; Wang F; Wang H; Sun J
Colloids Surf B Biointerfaces; 2014 May; 117():122-7. PubMed ID: 24632038
[TBL] [Abstract][Full Text] [Related]
13. Self-assembling PEG-p(CL-co-TMC) copolymers for oral delivery of poorly water-soluble drugs: a case study with risperidone.
Ould-Ouali L; Noppe M; Langlois X; Willems B; Te Riele P; Timmerman P; Brewster ME; Ariën A; Préat V
J Control Release; 2005 Feb; 102(3):657-68. PubMed ID: 15681087
[TBL] [Abstract][Full Text] [Related]
14. Self-microemulsifying drug delivery system (SMEDDS) improves anticancer effect of oral 9-nitrocamptothecin on human cancer xenografts in nude mice.
Lu JL; Wang JC; Zhao SX; Liu XY; Zhao H; Zhang X; Zhou SF; Zhang Q
Eur J Pharm Biopharm; 2008 Aug; 69(3):899-907. PubMed ID: 18434109
[TBL] [Abstract][Full Text] [Related]
15. Comb-like amphiphilic copolymers bearing acetal-functionalized backbones with the ability of acid-triggered hydrophobic-to-hydrophilic transition as effective nanocarriers for intracellular release of curcumin.
Zhao J; Wang H; Liu J; Deng L; Liu J; Dong A; Zhang J
Biomacromolecules; 2013 Nov; 14(11):3973-84. PubMed ID: 24107101
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo evaluation of riccardin D nanosuspensions with different particle size.
Liu G; Zhang D; Jiao Y; Guo H; Zheng D; Jia L; Duan C; Liu Y; Tian X; Shen J; Li C; Zhang Q; Lou H
Colloids Surf B Biointerfaces; 2013 Feb; 102():620-6. PubMed ID: 23107940
[TBL] [Abstract][Full Text] [Related]
17. Anti-tumor efficacy of polymer-platinum(II) complex micelles fabricated from folate conjugated PEG-graft-α,β-poly [(N-amino acidyl)-aspartamide] and cis-dichlorodiammine platinum(II) in tumor-bearing mice.
Xue Y; Tang X; Huang J; Zhang X; Yu J; Zhang Y; Gui S
Colloids Surf B Biointerfaces; 2011 Jul; 85(2):280-8. PubMed ID: 21435846
[TBL] [Abstract][Full Text] [Related]
18. A nanoparticulate drug-delivery system for 20(S)-protopanaxadiol: formulation, characterization, increased oral bioavailability and anti-tumor efficacy.
Han M; Ma L; Yu X; Li Z; Guo Y; Wang X
Drug Deliv; 2016 Sep; 23(7):2410-2418. PubMed ID: 25564965
[TBL] [Abstract][Full Text] [Related]
19. In vivo pharmacokinetics, biodistribution and antitumor effect of amphiphilic poly(L-amino acids) micelles loaded with a novel all-trans retinoic acid derivative.
Tang J; Wang X; Wang T; Chen F; Zhou J
Eur J Pharm Sci; 2014 Jan; 51():157-64. PubMed ID: 24076464
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
